DPC

A mix of niche biotech operators and yield-focused funds are navigating a shifting macroeconomic environment in 2026, balancing operational headwinds with structural realignments.

SIGA Technologies (SIGA.US) reported $37 million in second-quarter TPOXX sales in 2026, securing critical government contracts despite a sharp drop in earnings per share. The health security firm is pivoting toward international markets, projecting upcoming deliveries worth $13 million alongside a $26 million commitment to the U.S. Strategic National Stockpile. In the broader healthcare space, Aditx Therapeutics (ADTX.US) faces mounting operational pressure following a June 2026 delisting notice and a subsequent executive shakeup that installed Jeffrey M. Busch as interim CEO. Meanwhile, diagnostic developer Biodesix (BDRX.US) continues its clinical pipeline expansion, having previously advanced enrollment in its CLARIFY real-world study for lung disease testing.

Industrial and resource exposure presents a parallel track. Midland-based ProPetro Holding (PUMP.US) has expanded its core hydraulic fracturing operations into wireline services and electric fleets, targeting emission reductions. For asset allocators, the Sprott Physical Gold Trust (PHYS.US) provides direct physical gold ownership as an alternative to derivative-heavy vehicles, and VinaCapital Vietnam Opportunity Fund (DPC.US) continues its regional mandate following a recent management transition.

On the fund side, duration strategies are undergoing recalibration. The Vanguard Long-Term Bond ETF (BLV.US) recently saw its Morningstar process rating downgraded to average, driven by concerns over its government bond tilt and extended duration risks. Other fixed-income vehicles like the WisdomTree Interest Rate Hedged High Yield Bond Fund (HYNX.US) and the SPDR Nuveen S&P High Yield Municipal Bond ETF (SHMD.US) maintain specialized yield mandates. Broad small-cap sentiment remains fragile; the SPDR S&P International Small Cap ETF (GWX.US) saw its momentum indicators turn negative in September 2026, though shares posted modest gains amid a global relief rally following recent Federal Reserve rate decisions.